Cardiol Therapeutics Inc trades with the ticker CRDL on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Looking to invest in Cardiol Therapeutics Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
CRDL.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $132.181MM
PE Ratio:
Price: 1.39 (Updated: 3/12/2024 0:47:16)
Cardiol Therapeutics Inc (CRDL) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how CRDL.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aurora Cannabis Inc, Avicanna Inc, Bausch Health Companies Inc, Cronos Group Inc, Charlotte’s Web Holdings, Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $222.521 | N/A | -0.115 | N/A% |
| Avicanna Inc (AVCN) | $43.759 | N/A | -4.217 | N/A% |
| Bausch Health Companies Inc (BHC) | $4,553.034 | N/A | 15.169 | N/A% |
| Cardiol Therapeutics Inc (CRDL) | $132.181 | N/A | -3.0 | N/A% |
| Cronos Group Inc (CRON) | $1,018.068 | N/A | 1.918 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Cardiol Therapeutics Inc (CRDL) vs Aurora Cannabis Inc (ACB)
- CRDL has higher EPS (-0.43 vs -79.2). ACB and CRDL both have P/E’s under 0.
- Cardiol Therapeutics Inc (CRDL) vs Avicanna Inc (AVCN)
- AVCN has higher EPS (-0.17 vs -0.43). AVCN and CRDL both have P/E’s under 0.
- Cardiol Therapeutics Inc (CRDL) vs Bausch Health Companies Inc (BHC)
- CRDL has higher EPS (-0.43 vs -2.18). BHC and CRDL both have P/E’s under 0.
- Cardiol Therapeutics Inc (CRDL) vs Cronos Group Inc (CRON)
- CRON has higher EPS (-0.24 vs -0.43). CRON and CRDL both have P/E’s under 0.
- Cardiol Therapeutics Inc (CRDL) vs Charlotte’s Web Holdings, Inc (CWEB)
- CRDL has higher EPS (-0.43 vs -0.44). CWEB and CRDL both have P/E’s under 0.
Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-3.00) than the industry average (0.33), indicating attractive valuation.
How to Buy CRDL stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
